Family Medicine Doctors in Kemblesville, PA Accepting Medicare
2 Family Medicine doctors found. Showing 1 - 2
 Dr. David Fahnestock Hoffman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Mcmaster Boulevard, Suite 1, Kemblesville, PA 19347 Phone: 610-255-4466 Fax: 610-255-4479 |
Dr. Mark Robert Harris, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 20 Mcmaster Boulevard, Suite 1, Kemblesville, PA 19347 Phone: 610-255-4466 Fax: 610-255-4479 |
News Archive
Landmark clinical trial to test third investigational drug for Alzheimer's disease
An international team led by Washington University School of Medicine in St. Louis has selected a third investigational drug to be tested in a worldwide clinical trial - already underway - aimed at finding treatments to prevent Alzheimer's disease.
More Medicare Advantage Plans get top ratings
Privately-run health insurance companies that contract with Medicare are scoring higher in a government-backed quality rating system designed to guide seniors to better medical care choices and service, the Obama administration announced Friday. The so-called "Medicare Advantage Plans" are performing better with more of them hitting four- and five-star ratings on the five-star scale, said U.S. Secretary for Health and Human Services Kathleen Sebelius and officials from the Centers for Medicare and Medicaid Services.
Overweight children up to five times more likely to suffer a heart attack or stroke before age of 65
Overweight children are three to five times more likely to suffer a heart attack or stroke before they reach the age of 65 warns the World Heart Federation, an NGO dedicated to the prevention of heart disease and stroke, on World Heart Day, Sunday 26th September 2004.
Decision Resources: 63% of neurologists select Tysabri as effective MS treatment
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the majority of surveyed U.S. neurologists selected Biogen Idec/Elan's Tysabri as the most effective therapy for the treatment of relapsing-remitting multiple sclerosis, when compared to other currently available agents.
› Verified 5 days ago